BMS-790052 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
More Information Supplier PageBMS-740808 is a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
More Information Supplier PageBMS-740808 is a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
More Information Supplier PageBMS-740808 is a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
More Information Supplier PageBMS-740808 is a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
More Information Supplier PageBleomycin sulfate is a mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus.
More Information Supplier PageBleomycin sulfate is a mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus.
More Information Supplier PageBleomycin sulfate is a mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus.
More Information Supplier Page